CLAIM CARD
A real-world observational cohort study by McGown et al. (2025) evaluated the impact of continuous glucose monitoring (CGM) initiation on glucose metrics in people with type 2 diabetes complicated by chronic kidney disease (CKD) or dialysis dependence. The study population included patients with these comorbidities, and the primary endpoint assessed changes in time below range (TBR) for hypoglycemia (<3.9 mmol/L) following CGM use. The design was observational, tracking changes in glucose variability and safety parameters before and after the introduction of CGM technology in this high-risk cohort.
Evidence grade: exploratory
Contradiction status: none
Publication: becb4785-6244-41cd-ba08-c47e58dca346
Provenance: Derivation Web chain
Citation Support
source_1Sidki 2026source_2Gravesteijn 2023source_3Lu 2021source_4Lee 2020source_5Franceschi 2026